223 related articles for article (PubMed ID: 30535292)
41. Ustekinumab for treatment of cutaneous Crohn's disease.
Abdat R; Markova A; Farraye FA; Lichtman MK
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329588
[TBL] [Abstract][Full Text] [Related]
42. Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease.
Hurabielle C; Schneider P; Baudry C; Bagot M; Allez M; Viguier M
J Dermatolog Treat; 2016; 27(1):67-9. PubMed ID: 25909366
[TBL] [Abstract][Full Text] [Related]
43. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
[TBL] [Abstract][Full Text] [Related]
44. Image Gallery: Pyoderma gangrenosum in a patient with myelodysplastic syndrome treated with azacitidine.
Pardo Pastor J; Redondo Capafons S; March López P; Nicolás Picó J; Pineda A; Martí JM
Br J Dermatol; 2017 Sep; 177(3):e68. PubMed ID: 28940271
[No Abstract] [Full Text] [Related]
45. Pneumocystis carinii pneumonia in a patient with pyoderma gangrenosum treated with cyclosporin.
De Silva BD; Buxton PK
Br J Dermatol; 2000 Sep; 143(3):683-4. PubMed ID: 10971375
[No Abstract] [Full Text] [Related]
46. Pyoderma gangrenosum associated with Takayasu's arteritis responding to cyclosporin.
Fearfield LA; Ross JR; Farrell AM; Costello C; Bunker CB; Staughton RC
Br J Dermatol; 1999 Aug; 141(2):339-43. PubMed ID: 10468813
[TBL] [Abstract][Full Text] [Related]
47. Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
Harris KA; Horst S; Gadani A; Nohl A; Annis K; Duley C; Beaulieu D; Ghazi L; Schwartz DA
Inflamm Bowel Dis; 2016 Feb; 22(2):397-401. PubMed ID: 26752468
[TBL] [Abstract][Full Text] [Related]
48. The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.
Capella GL; Frigerio E; Fracchiolla C; Altomare G
Scand J Gastroenterol; 1999 Feb; 34(2):220-1. PubMed ID: 10192206
[No Abstract] [Full Text] [Related]
49. Auricular pyoderma gangrenosum associated with Crohn's disease.
Ben Chaabane N; Hellara O; Ben Mansour W; Ben Mansour I; Melki W; Loghmeri H; Safer L; Bdioui F; Saffar H
Tunis Med; 2012 May; 90(5):414-5. PubMed ID: 22585655
[No Abstract] [Full Text] [Related]
50. Parastomal small bowel evisceration as a result of parastomal pyoderma gangrenosum in a patient with Crohn's disease.
Vornehm ND; Kelley SR; Ellis BJ
Am Surg; 2011 Jul; 77(7):E150-1. PubMed ID: 21944337
[No Abstract] [Full Text] [Related]
51. [Pyoderma gangrenosum: case report].
Cavka V; Situm M; Poduje S; Brtan A; Mandusić N; Cubrilović Z
Acta Med Croatica; 2012 Oct; 66 Suppl 1():25-8. PubMed ID: 23193817
[TBL] [Abstract][Full Text] [Related]
52. [A case of Crohn's disease associated with pyoderma gangrenosum].
Yonezawa M; Tsukioka M; Ogino H; Satomura Y; Nakagawa H; Unoura M; Miwa A
Nihon Shokakibyo Gakkai Zasshi; 1997 Nov; 94(11):762-6. PubMed ID: 9396332
[No Abstract] [Full Text] [Related]
53. [A case of Crohn's disease complicated by Guillain-Barrè syndrome during ustekinumab therapy].
Fukushima T; Nakajima K; Nozawa H; Nishino H; Sugita A; Koganei K; Futatsuki R; Yamaguchi S; Asano S; Matsushima M
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(4):324-329. PubMed ID: 30971669
[TBL] [Abstract][Full Text] [Related]
54. Is Ustekinumab the best treatment option in patients with Crohn's disease and coexistent multiple sclerosis?
Kapizioni C; Makris K; Kourkoulis P; Vrakas S; Michalopoulos G
Acta Gastroenterol Belg; 2019; 82(2):337. PubMed ID: 31314201
[No Abstract] [Full Text] [Related]
55. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.
Alkhouri N; Hupertz V; Mahajan L
Inflamm Bowel Dis; 2009 Jun; 15(6):803-6. PubMed ID: 18942748
[No Abstract] [Full Text] [Related]
56. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
57. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF; Grossberg AL; Gaspari AA
Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease.
Huff-Hardy K; Bedair M; Vazquez R; Burstein E
Inflamm Bowel Dis; 2017 Oct; 23(10):E49. PubMed ID: 28858074
[No Abstract] [Full Text] [Related]
59. Treatment of pyoderma gangrenosum associated with Crohn's disease.
Ohmori T; Yamagiwa A; Nakamura I; Nishikawa K; Saniabadi AR
Am J Gastroenterol; 2003 Sep; 98(9):2101-2. PubMed ID: 14499797
[No Abstract] [Full Text] [Related]
60. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
Shaath TS; Om A; Wolfe CM; Cohen GF
J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
